How Promising is the Vaccine News if People Won’t Take it? | Opinion

The last few weeks have brought a key tool in the fight against coronavirus: Moderna recently announced that a vaccine in Phase 3 trials was nearly 95 percent effective, exceeding even the most optimistic projections. Pfizer and BioNTech have also made similar announcements.

But excitement about a forthcoming vaccine has been tempered by the reality that more and more Americans report having serious reservations about getting vaccinated. Alongside further vaccine development, the incoming Biden administration will need a strategic communication and public outreach plan aimed at fighting what public health experts call vaccine hesitancy. Read more this article written by several authors including JB Fellows Katie Dickinson and Jennifer Roberts.